2023
DOI: 10.1016/j.bcp.2023.115453
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac glycoside neriifolin exerts anti-cancer activity in prostate cancer cells by attenuating DNA damage repair through endoplasmic reticulum stress

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 56 publications
0
1
0
Order By: Relevance
“…Neriifolin , a cardiac glycoside, has demonstrated its potential in suppressing malignant characteristics of prostate cancer cells. It achieves this by activating endoplasmic reticulum stress (ERS), which impacts the induction of antitumor inhibitory receptors, thereby enhancing DNA damage and apoptosis ( 131 ). Digoxin , a classic cardiac glycoside, exhibits potential in reducing inflammation and fibrosis in a mouse model of pulmonary fibrosis.…”
Section: New Findings Of Tcm Natural Products and Derivatives As Immu...mentioning
confidence: 99%
“…Neriifolin , a cardiac glycoside, has demonstrated its potential in suppressing malignant characteristics of prostate cancer cells. It achieves this by activating endoplasmic reticulum stress (ERS), which impacts the induction of antitumor inhibitory receptors, thereby enhancing DNA damage and apoptosis ( 131 ). Digoxin , a classic cardiac glycoside, exhibits potential in reducing inflammation and fibrosis in a mouse model of pulmonary fibrosis.…”
Section: New Findings Of Tcm Natural Products and Derivatives As Immu...mentioning
confidence: 99%